Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
184 hedge funds and large institutions have $1.23B invested in Avid Bioservices, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 69 increasing their positions, 66 reducing their positions, and 19 closing their positions.
92% more call options, than puts
Call options by funds: $899K | Put options by funds: $468K
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
32% more capital invested
Capital invested by funds: $933M → $1.23B (+$296M)
5% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 66
2% less funds holding
Funds holding: 187 → 184 (-3)
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$18.3M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$12.5M |
| 3 |
Bessemer Group
Woodbridge,
New Jersey
|
+$8.34M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.41M |
| 5 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$6.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$7.24M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.12M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.58M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.94M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.74M |
CDMO Hedge Fund Activity: Q3 2022 in Review
184 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2022, worth a combined $1.23B — up 32% from $933M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CDMO and 17 opened new positions — a net loss of 2 holders — while 66 trimmed existing stakes and 69 added.
The largest buyer was Jennison Associates, adding an estimated $18.3M. The largest seller was State Street, cutting an estimated $7.24M.
- 184 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2022, down from 187 in Q2 2022.
- Funds reported $1.23B of Avid Bioservices, Inc. Common Stock stock for Q3 2022, up 32% quarter-over-quarter.
- 17 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2022 and 19 closed out, a net change of -2 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2022 was Jennison Associates, an estimated $18.3M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2022 was State Street, an estimated $7.24M sold.
Based on aggregated 13F filings for Q3 2022.